Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
1.22
0.08 (7.02%)
At close: Aug 26, 2025, 3:59 PM
1.23
0.82%
After-hours: Aug 26, 2025, 04:30 PM EDT

Ovid Therapeutics Revenue

Ovid Therapeutics reported an annual revenue of $566K, reflecting a 44.5% growth. For the quarter ending June 30, 2025, Ovid Therapeutics generated $6.27M in revenue.
Revenue (ttm)
566K
Revenue Growth
44.5%
Price / Sales Ratio
116.97
Revenue / Employee
24.61K
Employees
23
Market Cap
86.75M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 566K +44.50%
Dec 31, 2023 391.69K -73.94%
Dec 31, 2022 1.5M -99.28%
Dec 31, 2021 208.38M +1551.60%
Dec 31, 2020 12.62M +Infinity%
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.